The aetiology of primary
B-cell lymphomas of the thymus is enigmatic. Although thymic follicular lymphoid
hyperplasia (TFH) is commonly associated with
myasthenia gravis (MG),
lymphoma is not a complication of this condition. The present paper reports a high frequency of monoclonal B-cell populations (6 of 18 cases; 33%) in micronodular
thymoma (MNT), a peculiar thymic
epithelial neoplasm with a B-cell-rich stroma, while B cells were consistently polyclonal in TFH (25 cases) and other types of
thymomas (15 cases) (p < 0.001). An intratumoural
lymphoma could be identified in three of the six monoclonal MNTs. Sequencing of the monoclonal IgH chain revealed partially overlapping VDJ gene usage in MNT and thymic mucosa-associated lymphoid tissue (
MALT) lymphomas. The neoplastic epithelium of MNTs, but not of TFH and other types of
thymoma, expressed high levels of dendritic cell, T-cell, and B-cell
chemoattractants, such as CCL18, CCR6, and CCL20. It is concluded that abnormal
chemokine expression in an epithelial tumour, MNT, can promote the recruitment of MALT, the emergence of monoclonal B cells, and, eventually, the subsequent development of mediastinal
lymphomas. More generally, the concept that expression of a 'high-risk' spectrum of
chemokines due to local or genetic factors may interfere with B-cell homeostasis and may contribute to
MALT lymphoma development in chronic inflammatory states is proposed.